$SNGX News Article - Soligenix Enters into Exclusive Option Agreement with Silk Road Therapeutics for Rights to Topical Pentoxifylline Designed to Treat Beh et's Disease https://marketwirenews.com/news-releases/soli...14962.html
Soligenix Inc. (SNGX) Stock Research Links
My Twitter: WhyteStocks